Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Tigecycline

U.S. FDA Requirements: Tigecycline

Pharmaceutical / Drug Definition : Inhibits protein translation in bacteria by binding to 30S ribosomal subunit and blocking entry of amino-acyl tRNA molecules into ribosomal A site, which in turn prevents incorporation of amino acid residues into elongating peptide chains

Registrar Corp assists Tigecycline companies with:

  • FDA Registration Tigecycline
  • FDA Listing Tigecycline
  • FDA Label Requirements and Exceptions Tigecycline
  • FDA Import Information Tigecycline
  • FDA Detentions Tigecycline (Tigecycline Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Tigecycline (Tigecycline Suppliers)
       - Processors Tigecycline
       - Repackers Tigecycline
       - Relabelers Tigecycline
       - Exporters Tigecycline
       - Importers Tigecycline
For more information about Tigecycline, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco